Bank of Jackson Hole Trust’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-160
Closed -$5.88K 322
2026
Q1
$5.88K Hold
160
﹤0.01% 435
2025
Q4
$8.14K Hold
160
﹤0.01% 410
2025
Q3
$8.88K Hold
160
﹤0.01% 382
2025
Q2
$11K Hold
160
0.01% 360
2025
Q1
$14.5K Hold
160
0.01% 352
2024
Q4
$13.8K Buy
+160
New +$17.3K 0.01% 346

Other funds holding NVO

Bank of Jackson Hole Trust's NVO Position: Q2 2026 in Review

Bank of Jackson Hole Trust sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 160 shares — an estimated $5.88K sold.

Bank of Jackson Hole Trust first reported a position in NVO in Q4 2024 and held it in 6 quarters. The position peaked at $14.5K in Q1 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Bank of Jackson Hole Trust reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • Bank of Jackson Hole Trust sold 160 Novo Nordisk shares in Q2 2026, an estimated $5.88K.
  • Bank of Jackson Hole Trust first reported a position in Novo Nordisk in Q4 2024 and held it in 6 quarters.
  • Bank of Jackson Hole Trust's Novo Nordisk position peaked at $14.5K in Q1 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Bank of Jackson Hole Trust's 13F filing for Q2 2026.